AC
BHC icon

Andromeda Capital’s Bausch Health BHC Stock Holding History

Andromeda Capital’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-30,791
Closed -$4.04M – 49
2014
Q3 		$4.04M Buy
30,791
+26,225
+574% +$3.13M 0.24% 96
2014
Q2 		$576K Buy
+4,566
New +$583K 0.04% 108

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return

Andromeda Capital's BHC Position: Q4 2014 in Review

Andromeda Capital sold out of Bausch Health (BHC) in Q4 2014, closing a stake of 30,791 shares — an estimated $4.04M sold.

Andromeda Capital first reported a position in BHC in Q2 2014 and held it in 2 quarters. The position peaked at $4.04M in Q3 2014. 496 funds tracked by Wall St. Rank hold BHC as of Q4 2014.

  • Andromeda Capital reported no remaining Bausch Health position as of Q4 2014 after selling out during the quarter.
  • Andromeda Capital sold 30,791 Bausch Health shares in Q4 2014, an estimated $4.04M.
  • Andromeda Capital first reported a position in Bausch Health in Q2 2014 and held it in 2 quarters.
  • Andromeda Capital's Bausch Health position peaked at $4.04M in Q3 2014.
  • 496 funds tracked by Wall St. Rank held Bausch Health as of Q4 2014.

Based on Andromeda Capital's 13F filing for Q4 2014, filed 17 Feb 2015.